CD99: A Cell Surface Protein with an Oncojanus Role in Tumors

被引:60
|
作者
Manara, Maria Cristina [1 ]
Pasello, Michela [1 ]
Scotlandi, Katia [1 ]
机构
[1] Rizzoli Orthopaed Inst, CRS Dev Biomol Therapies, Lab Expt Oncol, I-40136 Bologna, Italy
来源
GENES | 2018年 / 9卷 / 03期
关键词
CD99; tumor progression; antibodies; targeted therapies; EWINGS-SARCOMA CELLS; PRIMITIVE NEUROECTODERMAL TUMORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER CELLS; MIC2; EXPRESSION; MEMBRANE-PROTEIN; DOWN-REGULATION; SPLICE VARIANT; IMMUNOREACTIVITY; ENGAGEMENT;
D O I
10.3390/genes9030159
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The cell surface molecule CD99 has gained interest because of its involvement in regulating cell differentiation and adhesion/migration of immune and tumor cells. However, the molecule plays an intriguing and dual role in different cell types. In particular, it acts as a requirement for cell malignancy or as an oncosuppressor in tumors. In addition, the gene encodes for two different isoforms, which also act in opposition inside the same cell. This review highlights key studies focusing on the dual role of CD99 and its isoforms and discusses major critical issues, challenges, and strategies for overcoming those challenges. The review specifically underscores the properties that make the molecule an attractive therapeutic target and identifies new relationships and areas of study that may be exploited. The elucidation of the spatial and temporal control of the expression of CD99 in normal and tumor cells is required to obtain a full appreciation of this molecule and its signaling.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] Leukocytes with chromosome Y loss have reduced abundance of the cell surface immunoprotein CD99
    Mattisson, Jonas
    Danielsson, Marcus
    Hammond, Maria
    Davies, Hanna
    Gallant, Caroline J.
    Nordlund, Jessica
    Raine, Amanda
    Eden, Malin
    Kilander, Lena
    Ingelsson, Martin
    Dumanski, Jan P.
    Halvardson, Jonatan
    Forsberg, Lars A.
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [32] CBFA1 REGULATES THE EXPRESSION OF CD99, A EWING TUMORS MARKER
    Bertaux, K.
    Broux, O.
    Chauveau, C.
    Hardouin, P.
    Jeanfils, J.
    Devedjian, J. C.
    CALCIFIED TISSUE INTERNATIONAL, 2004, 74 : S53 - S53
  • [33] CD99 expression in normal brain and central nervous system tumors.
    Berbescu, EA
    Schelper, RL
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2001, 60 (05): : 520 - 520
  • [34] The predictive value of CK19 and CD99 in pancreatic endocrine tumors
    Ali, Abdullah
    Serra, Stefano
    Asa, Sylvia L.
    Chetty, Runjan
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (12) : 1588 - 1594
  • [35] Prevalence of CD99 protein expression in pancreatic endocrine tumours (PETs)
    Goto, A
    Niki, T
    Terado, Y
    Fukushima, J
    Fukayama, M
    HISTOPATHOLOGY, 2004, 45 (04) : 384 - 392
  • [36] Role of the adhesion molecule CD99 in platelet- neutrophil interactions
    Pliyev, Boris K.
    Shepelev, Alexander V.
    Ivanova, Anna V.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 91 (05) : 456 - 461
  • [37] CD99: A new mediator of osteoblastogenesis
    Sciandra, M.
    Marino, M. T.
    Manara, M. C.
    Grano, M.
    Picci, P.
    Scotlandi, K.
    BONE, 2011, 48 : S258 - S258
  • [38] CD99 at the crossroads of physiology and pathology
    Michela Pasello
    Maria Cristina Manara
    Katia Scotlandi
    Journal of Cell Communication and Signaling, 2018, 12 : 55 - 68
  • [39] CD99 Expression in Glioblastoma Molecular Subtypes and Role in Migration and Invasion
    Cardoso, Lais C.
    Soares, Roseli da S.
    Laurentino, Talita de S.
    Lerario, Antonio M.
    Marie, Suely K. N.
    Oba-Shinjo, Sueli Mieko
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (05)
  • [40] CD99 reactivity in mesenchymal chondrosarcoma
    Granter, SR
    Renshaw, AA
    Fletcher, CDM
    Bhan, AK
    Rosenberg, AE
    HUMAN PATHOLOGY, 1996, 27 (12) : 1273 - 1276